TT-00420
適応症:トリプルネガティブ乳がん(TNBC)
TT-01488
・Clinical trial at present time
FPI in China (this March to April)
Dose escalation in USA
TT-00973
・Target : AML & Solid tumor (Ovarian Cancer)
・Gate keeper F691L mutation
・Clinical trial at present time
FPI in this year
TT-00920
適応症:心不全
TT-01025
適応症:非アルコール性脂肪肝炎(NASH)
・Clinical Trial at present time
Proposal of Phase2 clinical trial to FDA this April
LG Chem conducts clinical trials in USA
Global right except China and Japan was hold by LG Chem